vimarsana.com
Home
Live Updates
TikoMed's ILB® mobilizes and modulates key growth facto
TikoMed's ILB® mobilizes and modulates key growth facto
TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS
/PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body's ability to self-repair and regenerate, today...
Related Keywords
Sweden ,
Richard Hayhurst ,
Anders Kristensson ,
Ann Logan ,
Prnewswire Tikomed ,
University Of Warwick ,
Scientific Director ,
Axolotl Consulting ,
Regenerative Medicine ,
Amyotrophic Lateral Sclerosis ,
Traumatic Brain Injury ,
Tikomed ,